20250310 McGuinness Institute Submission on Gene Technology Bill.pptx

sustainablefuture 865 views 14 slides Mar 10, 2025
Slide 1
Slide 1 of 14
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14

About This Presentation

On March 10 2025 Wendy McGuinness from the McGuinness Institute presented an oral submission to the Health Committee on the proposed Gene Technology Bill.


Slide Content

Gene Technology Bill March 2025 McGuinness Institute 1

A: Background Timeline of McGuinness Institute Publications on Genetic Engineering, Genetic Modification and Gene Technology 2002 2025 2013 2008 2020 2

3

B: Key Suggestions Add back in a precautionary approach Add back in the methodology (could be a refresh of the Hazardous Substances and New Organisms (Methodology) Order 1998 ) Take into account the intersection of gene technology and unknown capabilities (in particular AI). Take into account the possibility of foreign investors undertaking risks in NZ that they cannot do in their own country Align GM policy with exports/trade agreements Pandemic risk: Ensure labs are regularly and independently reviewed and reported upon. 4

B2: Cont. Schedule (from Hazardous Substances and New Organisms (Methodology) Order 1998) Methodology for making decisions under Part 5 of Act 5

B2: Cont. Schedule (from Hazardous Substances and New Organisms (Methodology) Order 1998) Methodology for making decisions under Part 5 of Act 6

B2: Cont. Schedule (from Hazardous Substances and New Organisms (Methodology) Order 1998) Methodology for making decisions under Part 5 of Act 7

B2: Cont. Schedule (from Hazardous Substances and New Organisms (Methodology) Order 1998) Methodology for making decisions under Part 5 of Act 8

B2: Cont. Schedule (from Hazardous Substances and New Organisms (Methodology) Order 1998) Methodology for making decisions under Part 5 of Act 9

B3: Take into account the intersection of gene technology and unknown capabilities (in particular AI). 10

B4: Take into account the possibility of foreign investors undertaking risks in NZ that they cannot do in their own country 11

B5: Align GM policy with exports/trade agreements 12

B6: Pandemic risk: Ensure labs are regularly and independently reviewed and reported upon. 13

Animal Markets and Zoonotic Disease Risk A Global Synthesis of a 15 Country Study, 2024   “Eight of the 10 mammalian species who share the highest number of viruses with humans are domestic species, including pigs, cattle, horses, sheep, and goats. An estimated 80% of pathogens carried by livestock can infect other species, such as ours.” (p. 86) 14
Tags